Hanmi Pharm. Statistics

Total Valuation

Hanmi Pharm. has a market cap or net worth of KRW 3.38 trillion. The enterprise value is 3.85 trillion.

Market Cap	3.38T
Enterprise Value	3.85T

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Hanmi Pharm. has 12.68 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class	n/a
Shares Outstanding	12.68M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	7.80%
Owned by Institutions (%)	21.61%
Float	6.20M

Valuation Ratios

The trailing PE ratio is 21.04 and the forward PE ratio is 18.43. Hanmi Pharm.'s PEG ratio is 1.10.

PE Ratio	21.04
Forward PE	18.43
PS Ratio	2.16
PB Ratio	3.13
P/TBV Ratio	3.27
P/FCF Ratio	17.99
P/OCF Ratio	n/a
PEG Ratio	1.10

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.77, with an EV/FCF ratio of 20.49.

EV / Earnings	23.96
EV / Sales	2.46
EV / EBITDA	10.77
EV / EBIT	14.81
EV / FCF	20.49

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.41.

Current Ratio	1.16
Quick Ratio	0.67
Debt / Equity	0.41
Debt / EBITDA	1.41
Debt / FCF	2.69
Interest Coverage	10.06

Financial Efficiency

Return on equity (ROE) is 15.44% and return on invested capital (ROIC) is 9.47%.

Return on Equity (ROE)	15.44%
Return on Assets (ROA)	8.37%
Return on Capital (ROIC)	9.47%
Revenue Per Employee	672.21M
Profits Per Employee	68.95M
Employee Count	2,330
Asset Turnover	0.81
Inventory Turnover	2.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.85% in the last 52 weeks. The beta is 0.51, so Hanmi Pharm.'s price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-16.85%
50-Day Moving Average	298,800.00
200-Day Moving Average	304,672.50
Relative Strength Index (RSI)	42.23
Average Volume (20 Days)	51,741

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hanmi Pharm. had revenue of KRW 1.57 trillion and earned 160.66 billion in profits. Earnings per share was 12,667.32.

Revenue	1.57T
Gross Profit	874.95B
Operating Income	260.02B
Pretax Income	226.05B
Net Income	160.66B
EBITDA	357.56B
EBIT	260.02B
Earnings Per Share (EPS)	12,667.32

Full Income Statement

Balance Sheet

The company has 200.22 billion in cash and 504.70 billion in debt, giving a net cash position of -304.48 billion or -24,012.57 per share.

Cash & Cash Equivalents	200.22B
Total Debt	504.70B
Net Cash	-304.48B
Net Cash Per Share	-24,012.57
Equity (Book Value)	1.24T
Book Value Per Share	85,111.11
Working Capital	97.99B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 222.89 billion and capital expenditures -35.01 billion, giving a free cash flow of 187.88 billion.

Operating Cash Flow	222.89B
Capital Expenditures	-35.01B
Free Cash Flow	187.88B
FCF Per Share	14,816.83

Full Cash Flow Statement

Margins

Gross margin is 55.86%, with operating and profit margins of 16.60% and 10.26%.

Gross Margin	55.86%
Operating Margin	16.60%
Pretax Margin	14.43%
Profit Margin	10.26%
EBITDA Margin	22.83%
EBIT Margin	16.60%
FCF Margin	12.00%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.19%.

Dividend Per Share	500.00
Dividend Yield	0.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	6
Payout Ratio	7.67%
Buyback Yield	0.08%
Shareholder Yield	0.27%
Earnings Yield	4.75%
FCF Yield	5.56%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

Hanmi Pharm. has an Altman Z-Score of 5.03.

Altman Z-Score	5.03
Piotroski F-Score	n/a